ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

This study is ongoing, but not recruiting participants.
Study NCT00004879.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Colorectal Cancer
Esophageal Cancer
Kidney Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
2 Additional conditions recognized in this trial
Carcinoma, Renal Cell
Colorectal Neoplasms
Esophageal Diseases
Esophageal Neoplasms
Kidney Neoplasms
Lung Neoplasms
Pancreatic Neoplasms
Prostatic Neoplasms
3 More general conditions related to this trial
Adenocarcinoma
Carcinoma
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Head and Neck Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Kidney Diseases
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Pancreatic Diseases
Prostatic Diseases
Rectal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
4 Interventions listed in this trial
panitumumab
5 Sponsors listed in this trial
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers